Status:
RECRUITING
Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania
Lead Sponsor:
Médecins du Monde
Collaborating Sponsors:
UNITAID
Burnet Institute
Conditions:
Hepatitis C
RDT
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The goal of this non-randomised, quasi-experimental, prospective comparative trial is to trial simplified care pathways for hepatitis C testing and treatment for people who inject drugs in Armenia, Ge...
Detailed Description
The investigators will conduct a study to trial a new, simplified, and lower cost clinical pathway and determine its feasibility, effectiveness, cost-effectiveness and acceptability in Armenia, Georgi...
Eligibility Criteria
Inclusion
- 18 years or older
- Able and willing to provide informed consent in local language
- Not currently on or previously had treatment for hepatitis C
- Attending site for needle / syringe program, OR self-reports ever injecting drugs
Exclusion
- Self-reported history of decompensate cirrhosis of the liver
- Women who are pregnant or breast-feeding
- Self-report other significant co-morbidities such as uncontrolled HIV infection, history of renal dysfunction, tuberculosis infection, or chronic hepatitis B infection
- Unable / unwilling to stop any contraindicated medications / supplements
Key Trial Info
Start Date :
October 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
3040 Patients enrolled
Trial Details
Trial ID
NCT06159504
Start Date
October 3 2024
End Date
December 1 2026
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute for Infectious Diseases
Yerevan, Armenia